XEI Scientific Appoint remX GmbH as Distributors for Germany
News May 06, 2014
XEI Scientific Inc, maker of the popular EVACTRON® De-Contaminator™ Plasma Cleaning System for electron microscopes and other vacuum chambers, has appointed remX GmbH, as distribution partners for their decontamination products in Germany.
XEI Scientific has appointed new distributors for Germany. remX GmbH is a company specializing in hardware and software solutions for Scanning Electron Microscopes for industry and universities.
Their specialty is in microscopy-based techniques such as electron microscopy and detectors such as EDX and SDD. They will also cover other European countries, particularly those speaking German. These include Austria, Poland, Hungary, Slovenia, Czech Republic, Switzerland (German speaking regions only) and the Netherlands.
The company is run by Marco Mostert, a specialist in instrumentation technology. He is very positive about this new partnership. “XEI is the technology leader with their Evactron De-Contaminator systems. The products are a natural fit to our current portfolio and we are confident we will be able to help XEI to grow in this market.” To contact remX in Bruchsal, Germany, customers are invited to visit their web site and learn more about the products offered: www.samx.eu.
Speaking about this new agreement, XEI Vice President of Sales & Marketing, Daniel R Kleinen says “Marco and his remX team provide us with an extremely experienced and well-qualified partner for the growing German market. The Evactron De-Contaminator uses a remote RF plasma source to produce gas-phase radicals that flow downstream through the chamber, eliminating contamination by chemical etch. XEI has now sold more than 1850 Evactron systems worldwide solving contamination problems in many different environments using instrumentation such as electron microscopes, FIBs and other vacuum sample chambers. Please visit our web site for the latest details, www.evactron.com."
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018